These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17560049

  • 1. Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans?
    Staines DR.
    Med Hypotheses; 2008; 70(1):137-40. PubMed ID: 17560049
    [Abstract] [Full Text] [Related]

  • 2. Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2008; 70(2):413-8. PubMed ID: 17582695
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
    Staines DR, Brenu EW, Marshall-Gradisnik S.
    Clin Ophthalmol; 2009; 3():259-61. PubMed ID: 19668576
    [Abstract] [Full Text] [Related]

  • 4. Is Parkinson's disease an autoimmune disorder of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2007; 69(6):1208-11. PubMed ID: 17562359
    [Abstract] [Full Text] [Related]

  • 5. Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?
    Staines DR.
    Med Hypotheses; 2005; 65(6):1154-60. PubMed ID: 16026937
    [Abstract] [Full Text] [Related]

  • 6. Is sudden infant death syndrome (SIDS) an autoimmune disorder of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2004; 62(5):653-7. PubMed ID: 15082084
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 8. Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
    Staines DR, Brenu EW, Marshall-Gradisnik S.
    Neuropsychiatr Dis Treat; 2009 Aug; 5():81-9. PubMed ID: 19557103
    [Abstract] [Full Text] [Related]

  • 9. Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?
    Staines D.
    Med Hypotheses; 2005 Aug; 65(1):29-31. PubMed ID: 15893112
    [Abstract] [Full Text] [Related]

  • 10. Postulated vasoactive neuropeptide autoimmunity in fatigue-related conditions: a brief review and hypothesis.
    Staines DR.
    Clin Dev Immunol; 2006 Mar; 13(1):25-39. PubMed ID: 16603442
    [Abstract] [Full Text] [Related]

  • 11. Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?
    Staines DR.
    Med Hypotheses; 2004 Mar; 62(5):646-52. PubMed ID: 15082083
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 13. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
    Nilsson SF, De Neef P, Robberecht P, Christophe J.
    Exp Eye Res; 1994 Apr 15; 58(4):459-67. PubMed ID: 7925682
    [Abstract] [Full Text] [Related]

  • 14. Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine's association with Gulf War syndrome?
    Staines D.
    Med Hypotheses; 2005 Apr 15; 65(3):591-4. PubMed ID: 16004938
    [Abstract] [Full Text] [Related]

  • 15. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K, Connell TD, Higgins D.
    J Neurosci; 2002 Aug 01; 22(15):6560-9. PubMed ID: 12151535
    [Abstract] [Full Text] [Related]

  • 16. Is Gulf War Syndrome an autoimmune disorder of endogenous neuropeptides, exogenous sandfly maxadilan and molecular mimicry?
    Staines DR.
    Med Hypotheses; 2004 Aug 01; 62(5):658-64. PubMed ID: 15082085
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity.
    Ganea D, Delgado M.
    Crit Rev Oral Biol Med; 2002 Aug 01; 13(3):229-37. PubMed ID: 12090463
    [Abstract] [Full Text] [Related]

  • 18. Is fibromyalgia an autoimmune disorder of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2004 Aug 01; 62(5):665-9. PubMed ID: 15082086
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.
    Delgado M, Leceta J, Ganea D.
    J Leukoc Biol; 2003 Jan 01; 73(1):155-64. PubMed ID: 12525573
    [Abstract] [Full Text] [Related]

  • 20. VIP- and PACAP-mediated immunomodulation as prospective therapeutic tools.
    Pozo D.
    Trends Mol Med; 2003 May 01; 9(5):211-7. PubMed ID: 12763526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.